■ Hydroxychloroquine and chloroquine retinal safety concers durign COVID-19 outbreak
Massimo Nicolò, Lorenzo Ferro Desideri, Matteo Bassetti, Carlo Enrico Traverso
Int Ophthalmol. 2020 Sep 18 : 1–7
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499926/
■ Acute chloroquine and hydroxychloroquine toxicity: a review for emergency clinicians
Alessandra Della Porta, Kasha Bornstein, Austin Coye et al
Am J Emerg Med. 2020 Oct; 38(10): 2209–2217
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369162/
■ Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavírus COVID-19
J.A. Gegúndez-Fernández, J. Zarranz-Ventura, G. Garay-Aramburu, ET AL
Sociedades oftalmológicas españolas
Arch Soc Esp Oftalmol. 2020 Jun; 95(6): 300–310
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183292/
■ COVID-19 and ocular implications: an update
Raffaele Nuzzi, Luigi Ludovico Carucci, Flavia Tripoli
J Ophthalmic Inflamm Infect. 2020; 10: 20
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471234/
■ The ocular surface, coronaviruses and COVID-19
Mark DP Willcox, Karen Walsh, Jason J Nichols et al
Clin Exp Optom. 2020 May 13 : 10.1111/cxo.13088
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272971/
■ Are eyes the windows to COVID-19? Systemic review and meta-analysis
Rina La Distia Nora, Ikhwanuliman Putera, Dhiya Farah Khalisha et al
BMJ Open Ophthalmol. 2020; 5(1): e000563
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476422/
■ Ocular findings in COVID-19 patients: a review of direct manifestationns and indirect effects on the eye
Federica Bertoli, Daniele Veritti, Carla Danese et al
J Ophthalmol. 2020; 2020: 4827304.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491448/
■ COVID-19: Ophthalmological aspects of the SARS-CoV 2 global pandemic
Jakob Siedlecki, Victor Brantl, Benedikt Schworm et al
Klin Monbl Augenheilkd. 2020 May; 237(5): 675–680
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295305/
■ Retinal findings in patients with COVID-19: Results from the SERPICO-19 study
Alessandro Invernizzi, Alessandro Torre, Salvatore Parrulli et al
EClinicalMedicine. 2020 Oct; 27: 100550.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502280/
■ The ocular manifestations and transmission of COVID-19: Recommendations for prevention
Dominique M. Dockery, Susannah G. Rowe, Marjorie A. Murphy, Magdalena G. Krzystolik
J Emerg Med. 2020 Jul; 59(1): 137–140
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205711/
■ Diabetic retinopathy screening and the COVID-19 pandemic in Brazil
Malerbi, Fernando Korn, Morales, Paulo Henrique Avila and Regatieri, Caio Vinicius Saito
Arq. Bras. Oftalmol., Aug 2020, vol.83, no.4, p.V-VI
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492020000400001&lng=pt&nrm=iso
■ COVID-19 and the eye: how much do we really know? A best evidence review.
Emparan, Juan Pablo Olivares-de et al.
Arq. Bras. Oftalmol., June 2020, vol.83, no.3, p.250-261
■ Implications of Covid-19 in ophthalmology
Pereira, André Luiz Netto et al.
Rev. bras.oftalmol., June 2020, vol.79, no.3, p.217-217
https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000300217&lng=pt&nrm=iso
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Estratificação de Risco Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Data: dezembro 2020